Related Experiment Video
Updated: May 8, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Mixed Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Cervix: A Rare Entity
Zheng Guona1, Shi Yabin1, Du Qian1
1Department of Pathology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Abstract:
Carcinoma admixed with neuroendocrine carcinoma of the cervix is a rare malignant tumor with high malignancy and poor prognosis, of which large cell neuroendocrine carcinoma with adenocarcinoma are particularly rare, which have been reported limitedly in the literature. Currently, in most specimens, this disease is identified as a human papillomavirus (HPV)-related tumor. In the present study, we report a patient with mixed large cell neuroendocrine carcinoma and adenocarcinoma of the cervix, in which the molecular characterization of the lesion highlighted the ubiquitous presence of HPV18 DNA in both the adenocarcinomatous and neuroendocrine components, suggesting a potential pathogenic role of the virus. And 2 years later, the large cell neuroendocrine carcinoma component but not the adenocarcinoma component of the tumor progressed to cervical lymph node metastasis. Because large cell neuroendocrine carcinoma is known to exhibit early metastasis and extremely poor prognosis, it is important to carefully detect the large cell neuroendocrine carcinoma component in cervical cancer. Therefore, accurate diagnosis coupled with a comprehensive literature review is essential to supplement epidemiological data and facilitate the development of standardized treatment strategies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cellular Adaptation IV: Dysplasia and Metaplasia